City

Boston (1)

Palo Alto (1)

San Francisco (1)

Stanford (1)

Overall Status

Completed (3)

Phase

early phase 1 (1)

n/a (1)

phase 4 (1)

Sponsor

Brigham and Women's Hospital (1)

Stanford University (1)

University of California, San Francisco (1)

Collaborator

Medical University of Silesia (1)

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)

Society for Urodynamics & Female Urology Foundation (1)

Stanford University (1)

Intervention

oxybutynin, solifenacin, tolterodine, trospium, or fesoterodine (1)

physical conditioning program (1)

transvaginal botulinum toxin a (bta) injection (1)

yoga practice program (1)

Study Documents

Intervention Type

drug (2)

other (1)

Funder Type

Other (3)

Study Type

Interventional (3)

urgency urinary

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Stress Incontinence, Female, Stress Incontinence, Urinary, Stress Incontinence Trial in Palo Alto, San Francisco (Yoga Practice

Completed

Stress Incontinence, Female
+6 more

Yoga Practice Program
Physical Conditioning Program

Palo Alto, California
+1 more

Feb 1, 2023

Urinary Incontinence, Urgency Urinary Trial in Boston (Oxybutynin, Solifenacin, Tolterodine, Sanctura or Toviaz)

Completed

Has Results

Urinary Incontinence
Urgency Urinary

Oxybutynin, Solifenacin, Tolterodine, Trospium, or Fesoterodine

Boston, Massachusetts

Brigham & Women's Hospital

Oct 21, 2022

Overactive Bladder, Bladder, Overactive, Urge Incontinence Trial in Stanford (Transvaginal botulinum toxin A (BTA) injection)

Completed

Overactive Bladder
+4 more

Transvaginal botulinum toxin A (BTA) injection

Stanford, California

Urology Clinic (Stanford University), 1000 Welch Road, Suite 100

Jul 14, 2022